NCT05744401 A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT05738486 A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05681819 A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT05658913 Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU) Status RECRUITING Phase N/A
NCT05655195 Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy Status RECRUITING Phase NA
NCT05619692 A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) Status COMPLETED Phase PHASE2
NCT05607615 A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease Status UNKNOWN Phase PHASE2
NCT05602727 Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008) Status TERMINATED Phase PHASE2
NCT05596994 7T MRI for Light Therapy in Patients With Mild Cognitive Impairment and Mild AD Status COMPLETED Phase NA
NCT05591027 Safety and Target Engagement of Centella Asiatica in Cognitive Impairment Status RECRUITING Phase PHASE1
NCT05578443 Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease Status RECRUITING Phase PHASE2
NCT05551741 A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD) Status COMPLETED Phase PHASE1
NCT05519137 Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia Status COMPLETED Phase NA
NCT05476783 A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT05463731 A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1) Status COMPLETED Phase PHASE3
NCT05462106 A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) Status RECRUITING Phase PHASE1/PHASE2
NCT05423522 Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT05363293 Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects Status COMPLETED Phase PHASE1/PHASE2